Target
Integrase
Ligand
BDBM50162329
Substrate
n/a
Meas. Tech.
ChEMBL_306087 (CHEMBL833588)
IC50
97000±n/a nM
Citation
 Deng, JLee, KWSanchez, TCui, MNeamati, NBriggs, JM Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors. J Med Chem 48:1496-505 (2005) [PubMed]  Article 
Target
Name:
Integrase
Synonyms:
Human immunodeficiency virus type 1 integrase
Type:
PROTEIN
Mol. Mass.:
32231.48
Organism:
Human immunodeficiency virus 1
Description:
ChEMBL_90865
Residue:
288
Sequence:
FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKVKIIRDYGKQMAGDDCVASRQDED
  
Inhibitor
Name:
BDBM50162329
Synonyms:
3-[4-(2-methyloxycarbonyl-3-thienylcarbamoyl)phenylcarboxamido]-2-thiophenecarboxylic acid | CHEMBL195502
Type:
Small organic molecule
Emp. Form.:
C20H16N2O6S2
Mol. Mass.:
444.481
SMILES:
COC(=O)c1sccc1NC(=O)c1ccc(cc1)C(=O)Nc1ccsc1C(=O)OC
Structure:
Search PDB for entries with ligand similarity: